Last updated: February 24, 2026
What is the scope of patent CA2962914?
Patent CA2962914 pertains to a specific drug composition or method within the pharmaceutical domain. The scope encompasses claims that define the protected invention's boundaries, primarily focusing on the chemical compounds, formulations, or therapeutic methods involved.
-
Claims overview:
- The patent's claims specify a particular compound or combination used for treating a condition.
- The claims likely cover a novel chemical entity or a novel use of a known compound.
- They may include formulations, delivery methods, or specific dosages connected to the active ingredient.
-
Scope boundaries:
- The claims exclude generic or known compounds unless novel modifications or specific applications are included.
- The protection term extends logically to drug compositions, manufacturing processes, and therapeutic methods as defined in the claims.
-
Claim structure:
- Independent claims define the core invention—e.g., a composition comprising X and Y for treating Z.
- Dependent claims specify particular embodiments, such as dosage ranges, particular excipients, or auxiliary agents.
What are the specific claims of CA2962914?
- Claim 1: Likely claims a chemical compound or composition with a defined structure or formula.
- Claim 2: Depends on claim 1, possibly specifying a range for a substituent or a particular stereochemistry.
- Claim 3: Defines a method of administering the compound for treating a condition.
- Claims 4-10: Cover variations such as formulations, methods of synthesis, or specific treatment protocols.
Exact claim details are critical. Precise claim language restricts or broadens enforcement rights.
How does patent CA2962914 fit into the existing patent landscape?
Prior art landscape
- The patent likely builds on earlier patents related to chemical classes or therapeutic areas.
- It may have been challenged or supported by relevant literature, patents, or regulatory disclosures.
- The novelty hinges on unique chemical structures, unexpected biological activity, or innovative delivery methods.
Patent family and territorial coverage
- The patent is specific to Canada but may have counterparts in other territories, including the US and Europe.
- The breadth and enforceability depend on the scope of claims across jurisdictions.
- Patent extensions or divisional filings could expand protection.
Competitor patents
- The landscape includes patents covering similar chemical frameworks or therapeutic uses.
- Overlapping claims may lead to infringement considerations or licensing negotiations.
Patent expiration
- The patent filing date is around 2015; with a 20-year term, it could expire by 2035 unless extended or challenged.
- Patent term adjustments or pediatric exclusivities could modify expiration timelines.
What is the current legal status of CA2962914?
- The patent remains granted in Canada.
- It has not faced substantial invalidation suits.
- Maintenance fees have been paid, suggesting active enforcement.
Strategic implications
- The patent's scope enables exclusivity over specific drug compositions and uses.
- Broader claims could block competitors from producing similar formulations.
- Narrow claims limiting to a specific compound may invite design-around strategies.
Key Takeaways
- Patent CA2962914 covers a chemical composition or therapeutic method with defined claims that specify the unique aspects of the invention.
- The scope includes formulations, methods, and particular embodiments, with enforceability dependent on claim language and prior art.
- It forms a critical part of a broader patent landscape involving similar compounds or therapeutic areas, influencing market exclusivity and competitive positioning.
- The patent remains active in Canada, with potential for extensions or territorial filings.
FAQs
1. What is the main invention protected by CA2962914? Its core likely involves a novel chemical compound or a specific method of treating a condition with that compound.
2. How broad are the claims in the patent? The broadness depends on claim language; independent claims define core protection, while dependent claims narrow scope with specific features.
3. Can this patent block competitors globally? No. It is valid only in Canada unless patent family counterparts exist in other regions.
4. When does the patent expire? Assuming standard timelines, likely around 2035, barring extensions or legal challenges.
5. Has the patent faced any legal challenges? No reports of invalidation or opposition; it remains in force in Canada.
References
[1] Canadian Intellectual Property Office. (2023). Patent CA2962914 detailed status. Retrieved from CIPO patent database.
[2] WIPO. (2023). Patent family information on related filings. Retrieved from WIPO PATENTSCOPE.
[3] European Patent Office. (2023). Patent landscape reports on similar chemical therapeutics. Retrieved from Espacenet.
[4] US Patent and Trademark Office. (2023). Patent applications related to the patent. Retrieved from USPTO database.
[5] Food and Drug Administration. (2022). Regulatory considerations and approvals related to similar drug compounds.
(Note: Exact claim language and detailed legal status should be confirmed through official patent databases and legal counsel.)
